PURE BIOSCIENCE, INC. (PURE) › Capital ExpendituresPURE BIOSCIENCE, INC. (PURE) — Capital ExpendituresAnnual figures by fiscal year, from SEC filings.2011: $14.0K2012: $10.0K2013: $12.0K2014: $21.0K2015: $81.0K2016: $390.0K2017: $206.0K2018: $19.0K2019: $7.0K2020: $58.0K2021: $521.0K2022: $81.0K2023: $33.0K$33.0K2011Capital Expenditures (USD)2023Fiscal YearCapital ExpendituresChange YoY2023$33.0K-59.3%2022$81.0K-84.5%2021$521.0K+798.3%2020$58.0K+728.6%2019$7.0K-63.2%2018$19.0K-90.8%2017$206.0K-47.2%2016$390.0K+381.5%2015$81.0K+285.7%2014$21.0K+75.0%2013$12.0K+20.0%2012$10.0K-28.6%2011$14.0K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per Share